Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
JAMA Network Open
|
February 3, 2026
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-Analysis
Jonas Willmann, Camilla von Wachter, Ronja Zehnder, et al.
Current Developments in Nutrition
|
October 27, 2025
Micronutrient Biomarker Selection and Assay Methods and Performance in Double-Blind, Randomized, Controlled Micronutrient Dose Response (MiNDR) Trials among Women of Reproductive Age and Pregnant Women in Rural Bangladesh
Sulagna Bandyopadhyay, Anjan Kumar Roy, Sarah Baker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2025
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy
Jonas Willmann, Sarah Baker, Hanbo Chen, et al.
Environmental Research
|
June 21, 2023
Anthropometric measures and arsenic methylation among pregnant women in rural northern Bangladesh
Tyler J S Smith, Ana Navas-Acien, Sarah Baker, et al.
JAMA Oncology
|
September 29, 2022
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial
Robert Olson, Will Jiang, Mitchell Liu, et al.
Journal of Clinical Epidemiology
|
March 10, 2021
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review
Tanja A Stamm, Margaret R Andrews, Erika Mosor, et al.
BMC Oral Health
|
July 10, 2021
Selective Caries Removal in Permanent Teeth (SCRiPT) for the treatment of deep carious lesions: a randomised controlled clinical trial in primary care
Jan E Clarkson, Craig R Ramsay, David Ricketts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 11, 2025
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial
Aiden Kooyman, Jee Suk Chang, Mitchell Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2023
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
Reno Eufemon Cereno, Benjamin Mou, Sarah Baker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases
Robert Olson, Mitchell Liu, Alanah Bergman, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
JAMA Network Open
|
February 3, 2026
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-Analysis
Jonas Willmann, Camilla von Wachter, Ronja Zehnder, et al.
Current Developments in Nutrition
|
October 27, 2025
Micronutrient Biomarker Selection and Assay Methods and Performance in Double-Blind, Randomized, Controlled Micronutrient Dose Response (MiNDR) Trials among Women of Reproductive Age and Pregnant Women in Rural Bangladesh
Sulagna Bandyopadhyay, Anjan Kumar Roy, Sarah Baker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2025
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy
Jonas Willmann, Sarah Baker, Hanbo Chen, et al.
Environmental Research
|
June 21, 2023
Anthropometric measures and arsenic methylation among pregnant women in rural northern Bangladesh
Tyler J S Smith, Ana Navas-Acien, Sarah Baker, et al.
JAMA Oncology
|
September 29, 2022
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial
Robert Olson, Will Jiang, Mitchell Liu, et al.
Journal of Clinical Epidemiology
|
March 10, 2021
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review
Tanja A Stamm, Margaret R Andrews, Erika Mosor, et al.
BMC Oral Health
|
July 10, 2021
Selective Caries Removal in Permanent Teeth (SCRiPT) for the treatment of deep carious lesions: a randomised controlled clinical trial in primary care
Jan E Clarkson, Craig R Ramsay, David Ricketts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 11, 2025
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial
Aiden Kooyman, Jee Suk Chang, Mitchell Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2023
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
Reno Eufemon Cereno, Benjamin Mou, Sarah Baker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases
Robert Olson, Mitchell Liu, Alanah Bergman, et al.
Page
of 13